← SynDRA
MORNIFLUMATE
SynDRA canonical compound SYN0031015 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Mechanism of action | anti-inflammatory agent |
|---|
| Indication | pain relief |
|---|
| Disease area | neurology/psychiatry |
|---|
All known targets
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- NR1I2
- HTR2A
- HTR2B
- PDE4D
- KCNH2
- NPY1R
- HRH3
- HTR1A
- HTR2C
- HTR3A
- MAOA
- MC3R
- MLNR
- ADORA1
- HRH1
- NR3C1
- OPRD1
- OPRK1
- OPRM1
- PDE3A
- PGR
- SLC29A1
- SLC6A2
- SLC6A3
- SLC6A4
- HRH2
- HDAC6
- ADORA2A
- GHSR
- ADORA3
- ADRA1A
- ADRA2A
- ADRA2B
- ADRA2C
- ADRB1
- ADRB2
- AGTR1
- AVPR1A
- AVPR2
- BDKRB2
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- 5HT2A
- CP1A2
- CP2C9
- CP3A7
- ESRRA
- IP6K1
- NF2L2
Drug classes
ATC classes
- M01A · ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS
Cross-references
Synonyms
- Morniflumato
- Niflumic acid .beta.-morpholinoethyl ester
- UP-164
- UNII-R133MWH7X1
- 2-Morpholinoethyl 2-((3-(trifluoromethyl)phenyl)amino)nicotinate
- R133MWH7X1
- Morniflumatum
- 2-morpholin-4-ylethyl 2-[3-(trifluoromethyl)anilino]pyridine-3-carboxylate
- Morniflumate [USAN:INN]
- Morniflumatum [INN-Latin]
- Morniflumato [INN-Spanish]
- Nifluminsaeure 2-morpholinoethylester
- UP 164
- Morniflumate (USAN)
- Niflumic acid beta-morpholinoethyl ester
- AC1Q4JLB
- AC1L2HFJ
- DSSTox_RID_97471
- DSSTox_CID_31587
- DSSTox_GSID_57798
- SCHEMBL50683
- CHEMBL2105059
- DTXSID6057798
- DTXCID7031587
- beta-morpholinoethyl niflumate
- RefChem:159735
- M01AX22
- Flomax;UP 164
- MORNIFLUMATE [USAN]
- NIFLUMIC ACID .BETA.-MORPHOLINOETHYL ESTER
- LDXSPUSKBDTEKA-UHFFFAOYSA-N
- MORNIFLUMATE [INN]
- MORNIFLUMATE [MART.]
- MORNIFLUMATE [WHO-DD]
- orb1306958
- 2-Morpholinoethyl 2-(3-trifluoromethylanilino)nicotinat
- SCHEMBL29363251
- CHEBI:136018
Look up MORNIFLUMATE in the interactive SynDRA portal →